Global Biotech Stocks

Cingulate

Market Cap: US$21.5m

A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

Arterra Bioscience

Market Cap: €18.2m

A research-based biotech company, engages in the research and development of various ingredients and natural solutions.

Coral Laboratories

Market Cap: ₹1.9b

Manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.

MediPharm Labs

Market Cap: CA$29.5m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Curis

Market Cap: US$21.1m

A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.

Tissue Regenix Group

Market Cap: UK£15.7m

A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.

Evaxion

Market Cap: US$20.8m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Allarity Therapeutics

Market Cap: US$20.8m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

Daesung Microbiological Labs

Market Cap: ₩29.3b

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

Panchsheel Organics

Market Cap: ₹1.8b

Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.

1CM

Market Cap: CA$28.3m

Operates as a multi-jurisdictional cannabis company in Canada.

Citius Pharmaceuticals

Market Cap: US$20.2m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

Kimia Biosciences

Market Cap: ₹1.8b

Manufactures and sells active pharmaceutical ingredients (APIs) in India.

Finch Therapeutics Group

Market Cap: US$20.1m

A clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.

Noxopharm

Market Cap: AU$30.7m

A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.

Harvard Bioscience

Market Cap: US$19.9m

Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.

Synlogic

Market Cap: US$19.9m

A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.

Read-Gene

Market Cap: zł72.6m

Engages in the detection, prevention, and treatment of various types of cancer.

Biofrontera

Market Cap: €16.8m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

SenzaGen

Market Cap: SEK 185.3m

Provides non-animal tests for assessing allergenicity.

WooGene B&G

Market Cap: ₩26.9b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

May & Baker Nigeria

Market Cap: ₦28.0b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Aytu BioPharma

Market Cap: US$18.5m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

IDT Australia

Market Cap: AU$27.9m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.

BriaCell Therapeutics

Market Cap: CA$25.2m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Quest Laboratories

Market Cap: ₹1.6b

Manufactures and sells pharmaceutical formulations in India.

Vaishali Pharma

Market Cap: ₹1.6b

Engages in the pharmaceutical business in India and internationally.

BioInfra

Market Cap: ₩25.0b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

Biovica International

Market Cap: SEK 167.4m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Telescope Innovations

Market Cap: CA$24.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

IXICO

Market Cap: UK£13.0m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Welgene BiotechLtd

Market Cap: NT$522.0m

Provides genetic testing services.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م825.3m

Develops, produces, and sells pharmaceutical products in Egypt.

Parnax Lab

Market Cap: ₹1.5b

Engages in the manufacture and export of pharmaceutical formulations in India and internationally.

Devonian Health Group

Market Cap: CA$23.8m

Engages in the development of botanical drugs.

Bionano Genomics

Market Cap: US$17.0m

Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.